Rache Beatriz, Rocha Rudi, Medeiros Luciana Alves de, Okada Letícia Martins, Ferrari Gerson, Zeng Hongmei, Bigoni Alessandro, Curado Maria Paula, Azeredo Catarina M, Rezende Leandro F M
University of California, Los Angeles (UCLA), Anderson School of Management, Los Angeles, CA, USA.
Instituto de Estudos para Políticas de Saúde, São Paulo, SP, Brazil.
Lancet Reg Health Am. 2024 Oct 4;39:100904. doi: 10.1016/j.lana.2024.100904. eCollection 2024 Nov.
Cardiovascular disease (CVD) and cancer are the first and second leading causes of death in Brazil and worldwide. However, an ongoing epidemiological transition in which cancer surpasses CVD has been observed in many high and middle-income countries. In this study, we provided a nationwide analysis of the transition towards cancer mortality predominance over CVD mortality in Brazil.
We leveraged data from 5570 municipalities using the Mortality Information System and classified the causes of death using ICD-10 codes. Age-standardized CVD and cancer mortality rates were calculated annually between 2000 and 2019. Mortality rate ratios (MRRs = CVD rates divided by cancer rates) described the predominance of cancer or CVD mortality across municipalities and states. Choropleth maps displayed state-specific MRRs and the transition in the predominant cause of death over time.
From 2000 to 2019, CVD mortality rates declined in 25 out of 27 states, whereas cancer mortality increased in 15 states, indicating a shift towards cancer predominance. While in 2000 cancer mortality was lower than CVD in all states and only exceeded the latter in 7% of the municipalities, by 2019 the gap narrowed considerably, with 13% of municipalities displaying higher cancer mortality rates vs CVD mortality rates. Additionally, higher household income correlated with higher mortality from cancer vs CVD.
An ongoing epidemiological transition in which cancer mortality surpasses CVD mortality is occurring in Brazil, particularly in municipalities with higher household incomes. Our findings may provide important information for policymakers and public health practitioners in Brazil.
National Council for Scientific and Technological Development (CNPq).
心血管疾病(CVD)和癌症分别是巴西乃至全球的第一和第二大死因。然而,在许多高收入和中等收入国家,正在发生一种流行病学转变,即癌症超过心血管疾病成为首要死因。在本研究中,我们对巴西全国范围内癌症死亡率超过心血管疾病死亡率的转变进行了分析。
我们利用了来自5570个城市的死亡率信息系统数据,并使用国际疾病分类第十版(ICD - 10)编码对死因进行分类。计算了2000年至2019年期间每年的年龄标准化心血管疾病和癌症死亡率。死亡率比值(MRR = 心血管疾病死亡率除以癌症死亡率)描述了各城市和各州癌症或心血管疾病死亡率的优势情况。分级统计图展示了各州特定的MRR以及主要死因随时间的转变。
2000年至2019年期间,27个州中有25个州的心血管疾病死亡率下降,而15个州的癌症死亡率上升,这表明死亡优势正转向癌症。2000年时,所有州的癌症死亡率均低于心血管疾病死亡率,仅7%的城市癌症死亡率超过心血管疾病死亡率;到2019年,差距大幅缩小,13%的城市癌症死亡率高于心血管疾病死亡率。此外,家庭收入越高,癌症死亡率相对于心血管疾病死亡率就越高。
巴西正在发生一种流行病学转变,即癌症死亡率超过心血管疾病死亡率,特别是在家庭收入较高的城市。我们的研究结果可能为巴西的政策制定者和公共卫生从业者提供重要信息。
国家科学技术发展委员会(CNPq)。